Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $120,000 of MADRIGAL PHARMACEUTICALS INC. lobbying was just disclosed

None

$120,000 of MADRIGAL PHARMACEUTICALS INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Advocacy related to prescription drug access and pricing."

You can find more data on corporate lobbying on Quiver Quantitative.

MDGL Insider Trading Activity

MDGL Insider Trades

MDGL insiders have traded $MDGL stock on the open market 38 times in the past 6 months. Of those trades, 0 have been purchases and 38 have been sales.

Here’s a breakdown of recent trading of $MDGL stock by insiders over the last 6 months:

  • RICHARD S LEVY has made 0 purchases and 12 sales selling 5,682 shares for an estimated $2,928,716.
  • REBECCA TAUB has made 0 purchases and 3 sales selling 3,376 shares for an estimated $1,629,021.
  • WILLIAM JOHN SIBOLD (President and CEO) has made 0 purchases and 2 sales selling 3,240 shares for an estimated $1,494,862.
  • MARDI DIER (EVP and CFO) has made 0 purchases and 13 sales selling 3,165 shares for an estimated $1,359,381.
  • DAVID SOERGEL (Chief Medical Officer) has made 0 purchases and 2 sales selling 1,886 shares for an estimated $951,980.
  • CAROLE HUNTSMAN (Chief Commercial Officer) has made 0 purchases and 3 sales selling 1,329 shares for an estimated $630,321.
  • SHANNON T KELLEY (General Counsel) has made 0 purchases and 3 sales selling 1,052 shares for an estimated $499,671.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

MDGL Hedge Fund Activity

We have seen 176 institutional investors add shares of MDGL stock to their portfolio, and 166 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

MDGL Analyst Ratings

Wall Street analysts have issued reports on $MDGL in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Citizens issued a "Market Outperform" rating on 01/20/2026

To track analyst ratings and price targets for MDGL, check out Quiver Quantitative's $MDGL forecast page.

MDGL Price Targets

Multiple analysts have issued price targets for $MDGL recently. We have seen 7 analysts offer price targets for $MDGL in the last 6 months, with a median target of $649.0.

Here are some recent targets:

  • Alexandria Hammond from B of A Securities set a target price of $542.0 on 06/11/2026
  • Srikripa Devarakonda from Truist Securities set a target price of $709.0 on 05/13/2026
  • Liisa Bayko from Evercore ISI Group set a target price of $649.0 on 05/07/2026
  • Edward Nash from Canaccord Genuity set a target price of $578.0 on 05/07/2026
  • Andrew S. Fein from HC Wainwright & Co. set a target price of $620.0 on 05/06/2026
  • Eliana Merle from Barclays set a target price of $964.0 on 01/28/2026
  • Jonathan Wolleben from Citizens set a target price of $745.0 on 01/20/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles